|
|
 |
|
Viewing report
|
|
|
|
CNS European Market Competitive Strategies - Competitive Analysis, Profiles and Portfolio Strategies of the Top 20 CNS Therapeutic Manufacturers in Europe (2001 Edition)
ADIS, Jan 2002, Pages: 251
The European central nervous system (CNS) disorder marketplace is extremely competitive, a situation which is likely to increase in intensity in the period to 2005.
To succeed in this therapeutic area in the long term, participants need a range of different core competencies.
A high level of ability is critical across the whole range of required competencies in order to achieve success.
The 20 companies profiled in this report essentially fall into one of three categories.
Customers who bought this item also bought
CNS - Competitive Analysis, Profiles and Portfolio Strategies of CNS Therapeutic Manufacturers in the US, 2002
CNS Therapy Worldwide Market Survey: Analysis and Forecasts - Technology, Sales and Company Profiles
CNS Therapy US Market Survey: Analysis and Forecasts - Technology, Sales and Company Profiles
CNS Drug Licensing: Opportunities, Analysis, Rating and Ranking - A Worldwide Study
Drugs of Tomorrow 2001: Diabetes
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed
CNS Market: Year in Review - Sales Overview and Market News, 2000
The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D
Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs
PharmaVitae 2004: Solvay Global Analysis
Pipeline Insight: Antipsychotics - Novel Antipsychotics Driving Market Evolution
Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice
|
|
|
|
